JPMorgan Upgrades Thermo Fisher Scientific (TMO) to Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq set to open higher as CPI, bank earnings take focus; IBM tumbles
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Jefferies Lifts PT on Thermo Fisher Scientific (TMO) to $80
February 1, 2013 12:52 PM ESTJefferies raised its price target on Thermo Fisher Scientific (NYSE: TMO) from $66 to $80 following strong Q4 results.
"TMO's 4Q12 EPS of $1.36 walloped consensus (+$0.08) on stronger than expected organic revenue growth (+4% vs. +1% consensus). We are maintaining our 2013 EPS forecast of $5.40, but our price... More
Thermo Fisher Scientific (TMO) Tops Q4 EPS by 8c; Guides FY13 EPS, Revs
January 31, 2013 6:13 AM ESTThermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $1.36, $0.08 better than the analyst estimate of $1.28. Revenue for the quarter came in at $3.26 billion versus the consensus estimate of $3.13 billion.
Sees FY2013 EPS of $5.32-$5.46, versus the consensus of $5.43. Thermo Fisher Scientific sees FY2013... More
